Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2026 Filed Jan 8, 2026 21:33 UTC |
Chan MitchellChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 39,650 | $0.00 Strike: $14.18 | $0.00 |
DisclosureSEC source: 0001789335-26-000002 · primarydocument.xml · derivative · entry 2 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,650 Underlying: Common Stock · 39,650 shares Expires 2036-01-06 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:33 UTC |
Chan MitchellChief Financial Officer
|
GrantCommon Stock | 73,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001789335-26-000002 · primarydocument.xml · nonDerivative · entry 1 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,717 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:31 UTC |
Malzahn CraigChief Technology Officer
|
Tax withholdingCommon Stock | 1,238 | $14.40 | $17,827.20 |
DisclosureSEC source: 0002062007-26-000002 · primarydocument.xml · nonDerivative · entry 1 Malzahn Craig · CIK 0002062007 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,347 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, and January 2, 2024. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:31 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 18,247 | $14.40 | $262,756.80 |
DisclosureSEC source: 0001700659-26-000003 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,470 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:32 UTC |
Simpson CurranDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 18,559 | $14.40 | $267,249.60 |
DisclosureSEC source: 0001346164-26-000002 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,603 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:31 UTC |
Christmas Patrick J.Chief Strategy & Legal Officer
|
Tax withholdingCommon Stock | 9,793 | $14.40 | $141,019.20 |
DisclosureSEC source: 0001521123-26-000002 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Strategy & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,618 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jul 6, 2026 20:51 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantCommon Stock | 951 | $7.00 | $6,652.72 |
DisclosureSEC source: 0001346164-26-000006 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,418 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 1, 2025. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:38 UTC |
Simpson CurranDirector · Chief Executive Officer
|
SaleCommon Stock | 20,811 | $12.62 | $262,634.82 |
DisclosureSEC source: 0001346164-25-000005 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,162 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.50 to $12.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 29, 2025 Filed Oct 1, 2025 21:02 UTC |
Simpson CurranDirector · Chief Executive Officer
|
SaleCommon Stock | 7,624 | $10.03 | $76,468.72 |
DisclosureSEC source: 0001346164-25-000003 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 236,973 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $10.00 to $10.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:30 UTC |
Simpson CurranDirector · Chief Executive Officer
|
SaleCommon Stock | 7,734 | $10.02 | $77,494.68 |
DisclosureSEC source: 0001562180-25-006194 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 244,597 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $10.00 to $10.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 16:49 UTC |
Malzahn CraigChief Technology Officer
|
Tax withholdingCommon Stock | 234 | $8.93 | $2,089.62 |
DisclosureSEC source: 0001562180-25-006079 · primarydocument.xml · nonDerivative · entry 1 Malzahn Craig · CIK 0002062007 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,585 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 1, 2022. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 29, 2025. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:47 UTC |
Chan MitchellChief Financial Officer
|
Tax withholdingCommon Stock | 4,901 | $8.93 | $43,765.93 |
DisclosureSEC source: 0001562180-25-006078 · primarydocument.xml · nonDerivative · entry 1 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,968 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 16, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 29, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 21:17 UTC |
Christmas Patrick J.Chief Strategy & Legal Officer
|
Tax withholdingCommon Stock | 4,699 | $8.19 | $38,484.81 |
DisclosureSEC source: 0001562180-25-005618 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Strategy & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,411 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 1, 2025. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:53 UTC |
Simpson CurranDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 4,701 | $8.23 | $38,689.23 |
DisclosureSEC source: 0001562180-25-005334 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,331 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on July 1, 2025. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:31 UTC |
Bennett JeanDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004347 · primarydocument.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:31 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004347 · primarydocument.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:32 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004350 · primarydocument.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:32 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004350 · primarydocument.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:33 UTC |
Zachary JenniferDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004354 · primarydocument.xml · derivative · entry 2 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:33 UTC |
Zachary JenniferDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004354 · primarydocument.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,064 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:32 UTC |
Glucksmann AlexandraDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004349 · primarydocument.xml · derivative · entry 2 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:32 UTC |
Glucksmann AlexandraDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004349 · primarydocument.xml · nonDerivative · entry 1 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:37 UTC |
Fox Allan M.Director
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004355 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:37 UTC |
Fox Allan M.Director
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004355 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:32 UTC |
Mills Kenneth T.Director
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004351 · primarydocument.xml · derivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:32 UTC |
Mills Kenneth T.Director
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004351 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,871 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:33 UTC |
STUMP DAVID CDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004352 · primarydocument.xml · derivative · entry 2 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:33 UTC |
STUMP DAVID CDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004352 · primarydocument.xml · nonDerivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:31 UTC |
KARABELAS ARGERIS NDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004348 · primarydocument.xml · derivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:31 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004348 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:33 UTC |
Tasse DanielDirector
|
GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004353 · primarydocument.xml · derivative · entry 2 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:33 UTC |
Tasse DanielDirector
|
GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004353 · primarydocument.xml · nonDerivative · entry 1 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:49 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,602 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-25-003822 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,602 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:49 UTC |
Mills Kenneth T.Director
|
SaleCommon Stock | 20,602 | $7.91 | $163,046.29 |
DisclosureSEC source: 0001562180-25-003822 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 475,103 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $7.66 to $8.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:49 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 20,602 | $3.76 | $77,463.52 |
DisclosureSEC source: 0001562180-25-003822 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 495,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:05 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 30,752 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-25-002804 · primarydocument.xml · derivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,602 Underlying: Common Stock · 30,752 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:05 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 30,752 | $3.76 | $115,627.52 |
DisclosureSEC source: 0001562180-25-002804 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 475,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| February 01, 2025 Filed Apr 4, 2025 21:17 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 5,263 | $8.07 | $42,472.41 |
DisclosureSEC source: 0001562180-25-003009 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,717 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025 Read SEC document |
| February 01, 2025 Filed Apr 4, 2025 17:16 UTC |
Danos OlivierChief Scientific Officer
|
Tax withholdingCommon Stock | 5,452 | $8.07 | $43,997.64 |
DisclosureSEC source: 0001562180-25-003008 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,348 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025. Read SEC document |
| February 01, 2025 Filed Apr 4, 2025 21:17 UTC |
Christmas Patrick J.Chief Legal Officer
|
Tax withholdingCommon Stock | 4,700 | $8.07 | $37,929.00 |
DisclosureSEC source: 0001562180-25-003010 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,110 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 103,698 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001562180-25-000190 · primarydocument.xml · derivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,698 Underlying: Common Stock · 103,698 shares Expires 2035-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantCommon Stock | 64,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000190 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,980 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 13,891 | $7.73 | $107,377.43 |
DisclosureSEC source: 0001562180-25-000190 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,687 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:59 UTC |
Danos OlivierChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 95,721 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001562180-25-000189 · primarydocument.xml · derivative · entry 3 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,721 Underlying: Common Stock · 95,721 shares Expires 2035-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:59 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 59,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000189 · primarydocument.xml · nonDerivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,800 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:59 UTC |
Danos OlivierChief Scientific Officer
|
Tax withholdingCommon Stock | 12,630 | $7.73 | $97,629.90 |
DisclosureSEC source: 0001562180-25-000189 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,453 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 476,606 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001562180-25-000188 · primarydocument.xml · derivative · entry 3 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 476,606 Underlying: Common Stock · 476,606 shares Expires 2035-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantCommon Stock | 98,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000188 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,032 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
Simpson CurranDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 11,917 | $7.73 | $92,118.41 |
DisclosureSEC source: 0001562180-25-000188 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,120 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantStock Options (Right to buy) · Derivative | 223,350 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001562180-25-000186 · primarydocument.xml · derivative · entry 2 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,350 Underlying: Common Stock · 223,350 shares Expires 2035-01-02 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.